Page last updated: 2024-11-04

sulfamerazine and Meningitis, Pneumococcal

sulfamerazine has been researched along with Meningitis, Pneumococcal in 2 studies

Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COLEMAN, AH1
Loebe, FM1
Günther, J1

Other Studies

2 other studies available for sulfamerazine and Meningitis, Pneumococcal

ArticleYear
Pneumococcus meningitis; treatment with penicillin and sulfenamide.
    Journal of the National Medical Association, 1946, Volume: 38

    Topics: Humans; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Sulfamerazine

1946
[Initial results of a clinical trial of Mebacid (sulfamerazine) in the drug therapy of bacterial meningitis].
    Psychiatrie, Neurologie und medizinische Psychologie. Beihefte, 1975, Volume: 20-21

    Topics: Adolescent; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Humans; Male; Meningit

1975